Novel Bis-Artemisinin-Phloroglucinol hybrid molecules with dual anticancer and immunomodulatory Activities: Synthesis and evaluation.

[1]  Zhen-ye Xu,et al.  Study on the structure-activity relationship of dihydroartemisinin derivatives: Discovery, synthesis, and biological evaluation of dihydroartemisinin-bile acid conjugates as potential anticancer agents. , 2021, European journal of medicinal chemistry.

[2]  F. Oesch,et al.  The immunosuppressive activity of artemisinin‐type drugs towards inflammatory and autoimmune diseases , 2021, Medicinal research reviews.

[3]  S. Tsogoeva,et al.  Artemisinin‐derived dimers from a chemical perspective , 2021, Medicinal research reviews.

[4]  M. Foglio,et al.  Artemisinin-type drugs for the treatment of hematological malignancies , 2020, Cancer Chemotherapy and Pharmacology.

[5]  Xiaoping Yang,et al.  Artemisinins as Anticancer Drugs: Novel Therapeutic Approaches, Molecular Mechanisms, and Clinical Trials , 2020, Frontiers in Pharmacology.

[6]  Ming Lyu,et al.  The potential of artemisinins as anti-obesity agents via modulating the immune system. , 2020, Pharmacology & therapeutics.

[7]  Runyue Huang,et al.  Dihydroartemisinin ameliorates psoriatic skin inflammation and its relapse by diminishing CD8+ T-cell memory in wild-type and humanized mice , 2020, Theranostics.

[8]  W. Xu,et al.  Studies on the stereoselective synthesis and immunosuppressive activity of dihydroartemisinin-O-glycoside derivatives. , 2020, Bioorganic & medicinal chemistry letters.

[9]  Y. Tu,et al.  The birth of artemisinin. , 2020, Pharmacology & therapeutics.

[10]  B. Mirza,et al.  Artemisinin and its derivatives: a promising cancer therapy , 2020, Molecular Biology Reports.

[11]  T. Efferth,et al.  Repurposing of artemisinin-type drugs for the treatment of acute leukemia. , 2020, Seminars in cancer biology.

[12]  Fengming You,et al.  Novel use for old drugs: The emerging role of artemisinin and its derivatives in fibrosis. , 2020, Pharmacological research.

[13]  X. Wan,et al.  Artemisinin sensitizes tumor cells to NK cell-mediated cytolysis. , 2020, Biochemical and biophysical research communications.

[14]  Wanhong Liu,et al.  Ferroptosis: a novel mechanism of artemisinin and its derivatives in cancer therapy. , 2020, Current medicinal chemistry.

[15]  F. Gao,et al.  Artemisinin-derived hybrids and their anticancer activity. , 2020, European journal of medicinal chemistry.

[16]  E. Ferreira,et al.  Is prodrug design an approach to increase water solubility? , 2019, International journal of pharmaceutics.

[17]  Godefridus J. Peters,et al.  Combination therapies of Artemisinin and its derivatives as a viable approach for future cancer treatment. , 2019, Current pharmaceutical design.

[18]  Xuejun Jiang,et al.  Artemisinin compounds sensitize cancer cells to ferroptosis by regulating iron homeostasis , 2019, Cell Death & Differentiation.

[19]  Yu Cao,et al.  Artemisinin enhances the anti‐tumor immune response in 4T1 breast cancer cells in vitro and in vivo , 2019, International immunopharmacology.

[20]  R. Shrivastava,et al.  Current scenario of artemisinin and its analogues for antimalarial activity. , 2019, European journal of medicinal chemistry.

[21]  B. Kappes,et al.  Synthesis of Artemisinin-Derived Dimers, Trimers and Dendrimers: Investigation of Their Antimalarial and Antiviral Activities Including Putative Mechanisms of Action. , 2018, Chemistry.

[22]  Yan-hua Mou,et al.  Design, synthesis, cytotoxicity and mechanism of novel dihydroartemisinin-coumarin hybrids as potential anti-cancer agents. , 2018, European journal of medicinal chemistry.

[23]  Fangli Lu,et al.  Artemisinin and its derivatives in treating helminthic infections beyond schistosomiasis , 2018, Pharmacological research.

[24]  A. Zyad,et al.  More insights into the pharmacological effects of artemisinin , 2018, Phytotherapy research : PTR.

[25]  Karunakaran A Kalesh,et al.  Artemisinin as an anticancer drug: Recent advances in target profiling and mechanisms of action , 2017, Medicinal research reviews.

[26]  Wei Tang,et al.  Water-soluble artemisinin derivatives as promising therapeutic immunosuppressants of autoimmune diseases , 2017, Cellular & Molecular Immunology.

[27]  T. Efferth,et al.  Synthesis and cytotoxic activity of new artemisinin hybrid molecules against human leukemia cells. , 2017, Bioorganic & medicinal chemistry.

[28]  T. Efferth.  From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy. , 2017, Seminars in cancer biology.

[29]  Lifei Hou,et al.  Immune suppressive properties of artemisinin family drugs. , 2016, Pharmacology & therapeutics.

[30]  Y. Tu.  Artemisinin-A Gift from Traditional Chinese Medicine to the World (Nobel Lecture). , 2016, Angewandte Chemie.

[31]  S. Tsogoeva,et al.  Artemisinin-Derived Dimers: Potent Antimalarial and Anticancer Agents. , 2016, Journal of medicinal chemistry.

[32]  T. Efferth,et al.  Highly potent artemisinin-derived dimers and trimers: Synthesis and evaluation of their antimalarial, antileukemia and antiviral activities. , 2015, Bioorganic & medicinal chemistry.

[33]  T. Efferth,et al.  New efficient artemisinin derived agents against human leukemia cells, human cytomegalovirus and Plasmodium falciparum: 2nd generation 1,2,4-trioxane-ferrocene hybrids. , 2015, European journal of medicinal chemistry.

[34]  Lifei Hou,et al.  Anti-Inflammatory and Immunoregulatory Functions of Artemisinin and Its Derivatives , 2015, Mediators of inflammation.

[35]  Jian-Ping Zuo,et al.  Therapeutic effects of the artemisinin analog SM934 on lupus-prone MRL/lpr mice via inhibition of TLR-triggered B-cell activation and plasma cell formation , 2015, Cellular and Molecular Immunology.

[36]  T. Efferth,et al.  A Randomised, Double Blind, Placebo-Controlled Pilot Study of Oral Artesunate Therapy for Colorectal Cancer☆☆☆ , 2014, EBioMedicine.

[37]  G. Roman.  Mannich bases in medicinal chemistry and drug design , 2014, European Journal of Medicinal Chemistry.

[38]  M. T. Ansari,et al.  Malaria and artemisinin derivatives: an updated review. , 2013, Mini reviews in medicinal chemistry.

[39]  Hong Chen,et al.  Evaluation of the immunosuppressive activity of artesunate in vitro and in vivo. , 2013, International immunopharmacology.

[40]  Narendra Singh,et al.  Development of artemisinin compounds for cancer treatment , 2013, Investigational New Drugs.

[41]  K. Chibale,et al.  Artemisinin derivatives: a patent review (2006 – present) , 2012, Expert opinion on therapeutic patents.

[42]  Ying Li.  Qinghaosu (artemisinin): Chemistry and pharmacology , 2012, Acta Pharmacologica Sinica.

[43]  M. Ashraf,et al.  Artemisinins and immune system. , 2011, European journal of pharmacology.

[44]  J. Rautio,et al.  Prodrugs - an efficient way to breach delivery and targeting barriers. , 2011, Current topics in medicinal chemistry.

[45]  Jian-Ping Zuo,et al.  Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/lpr mice by inhibiting Th1 and Th17 cell responses. , 2011, Arthritis and rheumatism.

[46]  P. G. Rao,et al.  Artemisinin and its derivatives: a novel class of anti-malarial and anti-cancer agents. , 2010, Chemical Society reviews.

[47]  G. Firestone,et al.  Anticancer activities of artemisinin and its bioactive derivatives , 2009, Expert Reviews in Molecular Medicine.

[48]  D. Newton,et al.  Artemisinin dimer anticancer activity correlates with heme‐catalyzed reactive oxygen species generation and endoplasmic reticulum stress induction , 2009, International journal of cancer.

[49]  T. Efferth,et al.  The antiviral activities of artemisinin and artesunate. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[50]  N. White,et al.  Qinghaosu (Artemisinin): The Price of Success , 2008, Science.

[51]  Tycho Heimbach,et al.  Prodrugs: design and clinical applications , 2008, Nature Reviews Drug Discovery.

[52]  C. Nasveschuk,et al.  The [1, 3] O-to-C rearrangement: opportunities for stereoselective synthesis. , 2008, Organic & biomolecular chemistry.

[53]  V. Stella,et al.  Prodrug strategies to overcome poor water solubility. , 2007, Advanced drug delivery reviews.

[54]  Y. Li,et al.  Investigation of the immunosuppressive activity of artemether on T‐cell activation and proliferation , 2007, British journal of pharmacology.

[55]  Yuchun Wang,et al.  Artemisinin: current state and perspectives for biotechnological production of an antimalarial drug , 2006, Applied Microbiology and Biotechnology.

[56]  Narendra Singh,et al.  Targeted treatment of cancer with artemisinin and artemisinin-tagged iron-carrying compounds , 2005, Expert opinion on therapeutic targets.

[57]  Yu-yu Chou,et al.  Dibromomethane as One‐Carbon Source in Organic Synthesis: The Mannich Base Formation from the Reaction of Phenolic Compounds with a Preheated Mixture of Dibromomethane and Diethylamine , 2004 .

[58]  Ian D. Williams,et al.  Stereoselective Preparation of 10a- and 10-Aryl Derivatives of Dihydroartemisinin , 2003 .

[59]  T. Shapiro,et al.  Antimalarial, antiproliferative, and antitumor activities of artemisinin-derived, chemically robust, trioxane dimers. , 1999, Journal of medicinal chemistry.

[60]  T. Shapiro,et al.  Orally active, hydrolytically stable, semisynthetic, antimalarial trioxanes in the artemisinin family. , 1999, Journal of medicinal chemistry.

[61]  H. J. Woerdenbag,et al.  Stereochemistry-dependent cytotoxicity of some artemisinin derivatives. , 1997, Journal of natural products.

[62]  T. Mutabingwa,et al.  Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy! , 2005, Acta tropica.